car t research: Chimeric antigen receptor (CAR)-engineered γδ T cell represents a new type of immunotherapy that utilizes T cell immunity against various kinds of tumors. There is increasing evidence to report the exciting results of CAR-modified γδ T cells in the treatment of cancer. γδ T cells, an important population of T cells, have several advantages in fighting tumor cells such as strong cytotoxic effects on tumor cells.
